China has wrapped up a 10-month bribery investigation into pharmaceutical giant GlaxoSmithKline’s operations there, resulting in bribery charges against the former head of GSK China, according to Chinese law enforcement and published reports.
Bribery Probe Ends with Charges Against Former GSK China Top Executive
